Home > Healthcare > Medical Devices > Therapeutic Devices > Radiofrequency Ablation Devices Market

Radiofrequency Ablation Devices Market Trends

  • Report ID: GMI6323
  • Published Date: Jul 2023
  • Report Format: PDF

Radiofrequency Ablation Devices Market Trends

The growing prevalence of chronic diseases such as cancer, cardiovascular devices, gynecological disorders, diabetes, and several others is a key factor driving the industry progression. The increasing prevalence rate of cardiac arrhythmias, such as atrial fibrillation and ventricular tachycardia with an aging population base will offer unprecedented expansion opportunities to the industry gains. For instance, the World Health Organization (WHO) reports that more than 17.9 million deaths globally each year are attributed to cardiovascular disorders, that stands for around 32% of overall mortality worldwide.

Also, the Centers for Disease Control and Prevention (CDC) estimated that 12.1 million people will suffer from atrial fibrillation by 2030 in the U.S. owing to the increase in number of heart disorders, the demand for radiofrequency ablation devices for cardiac ablation.  Further, radiofrequency ablation is commonly used in the treatment of cancerous tumors, particularly in the liver, kidney, lung, and bone. For instance, according to the World Health Organization (WHO) estimates, cancer is one of the leading causes of death in the majority of countries globally.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Radiofrequency ablation devices market size reached USD 4.3 billion in 2022 and will record USD 10.4 billion by 2032 due to the increasing prevalence of chronic diseases, growing demand for minimally invasive treatments and higher advancements in medical technology

The hospitals segment is predicted to observe 9.3% CAGR from 2023-2032 owing to advantages, such as shorter hospital stays, faster patient recovery, and reduced risk of complications.

U.S. industry size was USD 1.6 billion in revenue size in 2022 and is predicted to witness substantial market growth through 2032 owing to the growing prevalence of chronic diseases such as cancer, diabetes and cardiovascular conditions

Some of the major radiofrequency ablation device providers include Avanos Medical, Inc., Stryker Corporation, Abbott Laboratories, Inc., Medtronic, Plc., Boston Scientific Corporation, Becton, Dickinson and Company (Venclose, Inc.), AngioDynamics, Inc., Hologic, Inc., and AtriCure, Inc.,

Radiofrequency Ablation Devices Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 347
  • Countries covered: 30
  • Pages: 267
 Download Free Sample